← Eichor
Condition: Graft Failure Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Graft Failure

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

HIIT in Pediatric Heart Transplant Recipients (MedBIKE™)
NA · 1 location(s) · University of Alberta · NCT05451979EndoForce Post Approval Study
Phase N/A · 2 location(s) · Phraxis, Inc. · NCT07146854Effectiveness and Health Economics of Endoluminal Treatment of Arteriovenous Graft Fistula.
Phase N/A · 1 location(s) · RenJi Hospital · NCT06470646CD34+ Selected Stem Cell for Poor Graft Function or Graft Failure
NA · 1 location(s) · NYU Langone Health · NCT06569082REgulatory T Cell Therapy to Achieve Immunosuppression REduction
Phase 2 · 7 location(s) · Singulera Therapeutics Inc. · NCT06552169Serum GLYcomics to Predict Graft Loss and Mortality After Liver Transplantation
Phase N/A · 1 location(s) · University Hospital, Ghent · NCT05866796Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant
NA · 1 location(s) · Johns Hopkins University · NCT05613010Abdominal Wall Transplant
NA · 1 location(s) · Duke University · NCT03310905Renal Function After Stentgraft Treatment Of Abdominal Aortic Aneurysm
NA · 1 location(s) · Vastra Gotaland Region · NCT04754659Imlifidase Prior to Kidney Transplant in Highly Sensitised Children
Phase 2 · 5 location(s) · Hansa Biopharma AB · NCT05753930Percutaneous Coronary RevascularizatiOn VERsus Coronary-Artery Bypass Grafting for Multivessel Disease in Patients With
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05532631Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies
Phase 2/Phase 3 · 1 location(s) · Hospital Israelita Albert Einstein · NCT03818334A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients
NA · 21 location(s) · W.L.Gore & Associates · NCT04671771Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants
Phase 1 · 1 location(s) · University of California, Los Angeles · NCT05525507Tacrolimus Pharmacokinetic Subpopulations
Phase N/A · 2 location(s) · University Hospital, Grenoble · NCT04526431Prevention of Graft Rejection in Hematopoietic Stem Cell Transplant (HSCT) Recipients
EARLY_Phase 1 · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT07244419Enhancing Renal Graft Function During Donor Anesthesia
NA · 1 location(s) · Nazmy Edward Seif · NCT03778944Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients Presenting a Missing Self-induced NK-mediated
NA · 1 location(s) · Hospices Civils de Lyon · NCT03955172Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
Phase N/A · 1 location(s) · Liverpool University Hospitals NHS Foundation Trust · NCT06025240High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
Phase N/A · 1 location(s) · Yigeng Cao,MD,PhD · NCT07205523A Clinical Study of Association Between Postoperative Dyslipidemia and Organ Rejection in Transplant Patients
Phase N/A · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT05994274Levothyroxine Supplementation for Heart Transplant Recipients
Phase 1 · 1 location(s) · University of California, San Francisco · NCT06428097A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients
Phase 3 · 13 location(s) · The University of Queensland · NCT05325008Endothelial Glycocalyx Damage in Brain Death Organ Donors
Phase N/A · 1 location(s) · University Hospital Hradec Kralove · NCT05609123XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
NA · 14 location(s) · XVIVO Perfusion · NCT06895070Graft Failure and Consequences of Coronary Artery Bypass Graft Surgery
Phase N/A · 1 location(s) · University of Edinburgh · NCT06800430Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
Phase N/A · 19 location(s) · Duke University · NCT06399302Allograft Dysfunction in Heart Transplant
Phase 4 · 1 location(s) · Paul Kim · NCT03102125A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Phase 2 · 26 location(s) · Deciphera Pharmaceuticals, LLC · NCT06619561OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
Phase N/A · 7 location(s) · Inova Health Care Services · NCT06939751
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.